KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Gross Profit (2016 - 2025)

Amgen has reported Gross Profit over the past 17 years, most recently at $17.6 billion for Q4 2025.

  • Quarterly results put Gross Profit at $17.6 billion for Q4 2025, up 591.35% from a year ago — trailing twelve months through Dec 2025 was $40.3 billion (up 96.1% YoY), and the annual figure for FY2025 was $35.4 billion, up 72.32%.
  • Gross Profit for Q4 2025 was $17.6 billion at Amgen, up from $9.2 billion in the prior quarter.
  • Over the last five years, Gross Profit for AMGN hit a ceiling of $17.6 billion in Q4 2025 and a floor of -$3.6 billion in Q4 2024.
  • Median Gross Profit over the past 5 years was $5.1 billion (2021), compared with a mean of $5.7 billion.
  • Biggest five-year swings in Gross Profit: crashed 170.52% in 2024 and later surged 591.35% in 2025.
  • Amgen's Gross Profit stood at $5.1 billion in 2021, then tumbled by 125.12% to -$1.3 billion in 2022, then surged by 494.72% to $5.1 billion in 2023, then crashed by 170.52% to -$3.6 billion in 2024, then surged by 591.35% to $17.6 billion in 2025.
  • The last three reported values for Gross Profit were $17.6 billion (Q4 2025), $9.2 billion (Q3 2025), and $6.2 billion (Q2 2025) per Business Quant data.